Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thyroid Cancer, Papillary × Surveys and Questionnaires × Clear all

Sponsor

Conditions

Breast Neoplasms 10 cyclopia sequence 7 Neoplasms 6 Multiple Myeloma 5 Fatigue 5 Neoplasms, Plasma Cell 4 Neoplasm Metastasis 4 Lung Neoplasms 4 Anxiety Disorders 4 Uterine Cervical Neoplasms 3 Tobacco Use Cessation 3 Primary Myelofibrosis 3 Leukemia 3 Dyspnea 3 Depression 3 Carcinoma, Non-Small-Cell Lung 3 Vomiting 2 Smoking Cessation 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Polycythemia Vera 2 Parasomnias 2 Pancreatic Neoplasms 2 Pain 2 Osteosarcoma 2 Kidney Neoplasms 2 Hodgkin Disease 2 Hematologic Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Agnosia 2

Interventions

lenvatinib 3 Sunitinib 3 cabozantinib 2 AZD 6244 2 vandetanib 1 tremelimumab 1 tovorafenib 1 tanespimycin 1 selpercatinib 1 pralsetinib 1 pembrolizumab 1 durvalumab 1 dabrafenib 1 copanlisib 1 cediranib 1 alectinib 1 Vorinostat 1 Vemurafenib 1 Thyroidectomy 1 Thyroid (USP) 1 Sorafenib 1 Pharmacogenomic Testing 1 Lenalidomide 1 Iodine-131 1 Gefitinib 1 Ferrosoferric Oxide 1 Ethanol 1 Bortezomib 1 Administration, Cutaneous 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡